1. Endometrial Cancer Global Clinical Trials Review, H2, 2012
Report Details:
Published:November 2012
No. of Pages: 107
Price: Single User License – US$2500
Endometrial Cancer Global Clinical Trials Review, H2, 2012
Summary
GlobalData''s clinical trial report, “Endometrial Cancer Global Clinical Trials Review, H2, 2012"
provides data on the Endometrial Cancer clinical trial scenario. This report provides elemental
information and data relating to the clinical trials on Endometrial Cancer. It includes an overview of
the trial numbers and their recruitment status as per the site of trial conduction across the globe.
The databook offers a preliminary coverage of disease clinical trials by their phase, trial status,
prominence of the sponsors and also provides briefing pertaining to the number of trials for the key
drugs for treating Endometrial Cancer. This report is built using data and information sourced from
proprietary databases, primary and secondary research and in-house analysis by GlobalData''s
team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and
relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America,
Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along
with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and
sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location,
sponsor type and many more

2. - Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Get your copy of this report @
http://www.reportsnreports.com/reports/210592-endometrial-cancer-global-clinical-trials-review-h2-2012.html
Major points covered in Table of Contents of this report include
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Endometrial Cancer 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Endometrial Cancer 24
Subjects Recruited Over a Period of Time 28
Prominent Sponsors 29
Top Companies Participating in Endometrial Cancer Therapeutics Clinical Trials 31
Prominent Drug Comparison 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Novartis AG 34
Clinical Trial Overview of Novartis AG 34
Sanofi 35
Clinical Trial Overview of Sanofi 35
GlaxoSmithKline plc 36
Clinical Trial Overview of GlaxoSmithKline plc 36
Eli Lilly and Company 37

3. Clinical Trial Overview of Eli Lilly and Company 37
Bristol-Myers Squibb Company 38
Clinical Trial Overview of Bristol-Myers Squibb Company 38
Merck & Co., Inc. 39
Clinical Trial Overview of Merck & Co., Inc. 39
Johnson & Johnson 40
Clinical Trial Overview of Johnson & Johnson 40
AEterna Zentaris Inc. 41
Clinical Trial Overview of AEterna Zentaris Inc. 41
Ipsen S.A. 42
Clinical Trial Overview of Ipsen S.A. 42
Precision Therapeutics, Inc. 43
Clinical Trial Overview of Precision Therapeutics, Inc. 43
Galena Biopharma, Inc. 44
Clinical Trial Overview of Galena Biopharma, Inc. 44
Ariad Pharmaceuticals, Inc. 45
Clinical Trial Overview of Ariad Pharmaceuticals, Inc. 45
EntreMed, Inc. 46
Clinical Trial Overview of EntreMed, Inc. 46
Novartis Pharmaceuticals Corporation 47
Clinical Trial Overview of Novartis Pharmaceuticals Corporation 47
MannKind Corporation 48
Clinical Trial Overview of MannKind Corporation 48
Pfizer Inc. 49
Clinical Trial Overview of Pfizer Inc. 49
Par Pharmaceutical Companies, Inc. 50
Clinical Trial Overview of Par Pharmaceutical Companies, Inc. 50
Genentech, Inc. 51
Clinical Trial Overview of Genentech, Inc. 51
AstraZeneca PLC 52
Clinical Trial Overview of AstraZeneca PLC 52
Xoft Inc. 53
Clinical Trial Overview of Xoft Inc. 53
Clinical Trial Overview of Top Universities / Institutes / Hospitals 54
The University of Texas M. D. Anderson Cancer Center 54
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 54
Case Comprehensive Cancer Center 55
Clinical Trial Overview of Case Comprehensive Cancer Center 55
Memorial Sloan Kettering Cancer Center 56
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 56
Dana-Farber Cancer Institute 57
Clinical Trial Overview of Dana-Farber Cancer Institute 57

4. National Taiwan University Hospital 58
Clinical Trial Overview of National Taiwan University Hospital 58
The University of New Mexico 59
Clinical Trial Overview of The University of New Mexico 59
Masonic Cancer Center 60
Clinical Trial Overview of Masonic Cancer Center 60
University of Wisconsin Madison 61
Clinical Trial Overview of University of Wisconsin Madison 61
University Health Network 62
Clinical Trial Overview of University Health Network 62
The Ohio State University 63
Clinical Trial Overview of The Ohio State University 63
New York University School of Medicine 64
Clinical Trial Overview of New York University School of Medicine 64
University of Virginia 65
Clinical Trial Overview of University of Virginia 65
Asan Medical Center 66
Clinical Trial Overview of Asan Medical Center 66
Osaka University 67
Clinical Trial Overview of Osaka University 67
Princess Margaret Hospital 68
Clinical Trial Overview of Princess Margaret Hospital 68
The Queensland Centre for Gynaecological Cancer 69
Clinical Trial Overview of The Queensland Centre for Gynaecological Cancer 69
University of Alabama at Birmingham 70
Clinical Trial Overview of University of Alabama at Birmingham 70
Rabin Medical Center 71
Clinical Trial Overview of Rabin Medical Center 71
USC Norris Comprehensive Cancer Center 72
Clinical Trial Overview of USC Norris Comprehensive Cancer Center 72
Leiden University Medical Center 73
Clinical Trial Overview of Leiden University Medical Center 73
Five Key Clinical Profiles 74
Appendix 104
Abbreviations 104
Definitions 104
Research Methodology 105
Secondary Research 105
About GlobalData 106
Contact Us 106
Disclaimer 106
Source 107

5. List of Tables
Endometrial Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2012* 8
Endometrial Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
Endometrial Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries,
2012* 10
Endometrial Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 11
Endometrial Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 12
Endometrial Cancer Therapeutics Clinical Trials, North America, Top Countries, 2012* 13
Endometrial Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 14
Endometrial Cancer Therapeutics Clinical Trials, Central and South America, Top Countries,
2012* 15
Endometrial Cancer Therapeutics Clinical Trials, BRIC Countries, 2012* 16
Endometrial Cancer Therapeutics Clinical Trials, G7 Countries, 2012* 17
Endometrial Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18
Endometrial Cancer Therapeutics Clinical Trials, E7 Countries, 2012* 19
Endometrial Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20
Endometrial Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2012* 21
Endometrial Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 22
Endometrial Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23
Endometrial Cancer Therapeutics Market, Global, Suspended Clinical Trials, 2012* 24
Endometrial Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 25
Endometrial Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2012* 26
Endometrial Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-
2011 28
Endometrial Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 30
Endometrial Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 32
Endometrial Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
33
Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG,
2012* 34
Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012* 35
Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline
plc, 2012* 36
Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and
Company, 2012* 37
Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers
Squibb Company, 2012* 38
Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co.,
Inc., 2012* 39
Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson &
Johnson, 2012* 40

6. Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AEterna Zentaris
Inc., 2012* 41
Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Ipsen S.A.,
2012* 42
Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Precision
Therapeutics, Inc., 2012* 43
Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Galena
Biopharma, Inc., 2012* 44
Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Ariad
Pharmaceuticals, Inc., 2012* 45
Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by EntreMed, Inc.,
2012* 46
Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis
Pharmaceuticals Corporation, 2012* 47
Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by MannKind
Corporation, 2012* 48
Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc.,
2012* 49
Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Par
Pharmaceutical Companies, Inc., 2012* 50
Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Genentech, Inc.,
2012* 51
Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca
PLC, 2012* 52
Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Xoft Inc., 2012*
53
Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of
Texas M. D. Anderson Cancer Center, 2012* 54
Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Case
Comprehensive Cancer Center, 2012* 55
Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan
Kettering Cancer Center, 2012* 56
Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber
Cancer Institute, 2012* 57
Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan
University Hospital, 2012* 58
Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of
New Mexico, 2012* 59
Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Masonic Cancer
Center, 2012* 60
Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of
Wisconsin Madison, 2012* 61

7. Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health
Network, 2012* 62
Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The Ohio State
University, 2012* 63
Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by New York
University School of Medicine, 2012* 64
Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of
Virginia, 2012* 65
Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical
Center, 2012* 66
Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka
University, 2012* 67
Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Princess
Margaret Hospital, 2012* 68
Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The Queensland
Centre for Gynaecological Cancer, 2012* 69
Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of
Alabama at Birmingham, 2012* 70
Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Rabin Medical
Center, 2012* 71
Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by USC Norris
Comprehensive Cancer Center, 2012* 72
Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden
University Medical Center, 2012* 73
List of Figures
Endometrial Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 8
Endometrial Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
Endometrial Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries,
2012* 10
Endometrial Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 11
Endometrial Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 12
Endometrial Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 13
Endometrial Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012*
14
Endometrial Cancer Therapeutics Clinical Trials, Central and South America, Top Countries (%),
2012* 15
Endometrial Cancer Therapeutics Clinical Trials, BRIC Countries (%), 2012* 16
Endometrial Cancer Therapeutics Clinical Trials, G7 Countries (%), 2012* 17
Endometrial Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18
Endometrial Cancer Therapeutics Clinical Trials, E7 Countries (%), 2012* 19
Endometrial Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20

8. Endometrial Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 21
Endometrial Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 22
Endometrial Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23
Endometrial Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-
2011 28
Endometrial Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 29
Endometrial Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 31
Endometrial Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
33
GlobalData Methodology 105
Contact: sales@reportsandreports.com for more information.